Home › NDC Lookup › RxCUI directory › RxCUI 412174

Ursodiol 200 MG Oral Capsule — RxCUI 412174

RxNorm drug concept · Semantic clinical drug
RxCUI 412174 Semantic clinical drug · SCD ● Current RxNorm concept 6 FDA products 6 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI412174
Official nameUrsodiol 200 MG Oral Capsule
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
FDA products mapped6
Package NDCs mapped6
Reported Medicaid activity (SDUD)2,600 prescriptions · 6 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Ursodiol: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • It depends on the product. Ursodiol capsules are used to dissolve certain cholesterol gallstones and to prevent gallstones during rapid weight loss. Urso 250, Urso Forte, and ursod...
  • It’s taken by mouth. For gallstones, capsules are usually divided into 2 or 3 doses a day. For PBC, tablets are taken in two to four divided doses with food. Follow your prescripti...
  • Stomach-related effects are the most common, such as belly pain, diarrhea, constipation, and nausea. Headache and dizziness can also happen. Call your doctor about severe belly pai...
  • Yes. Cholestyramine, colestipol, and aluminum-based antacids may reduce how much ursodiol works. Estrogens, birth control pills, and clofibrate can work against it for gallstones....
📖 Read our full Ursodiol guide →

🕸️ Concept Web — How Ursodiol 200 MG Oral Capsule Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Ursodiol 200 MG Oral Capsule RxCUI 412174

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 2

    The active substance itself — no strength, form, or brand attached yet.

    • Ursodeoxycholate 62427
    • Ursodiol 11065
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Reltone 2477891
  3. Dose forms 13

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Ursodeoxycholate Oral Capsule 618512
    • Ursodiol Oral Capsule 2645659
    • Ursodeoxycholate Oral Product 1159985
    • Ursodeoxycholate Pill 1159986
    • Ursodiol Oral Product 2662119
    • Ursodiol Pill 2660380
    • Ursodeoxycholate Oral Capsule [Reltone] 2477893
    • Ursodiol Oral Capsule [Reltone] 2656234
    • +5 more in this family
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 14 of 19 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Ursodiol 200 MG SCDC · 452499
  • Ursodeoxycholate Oral Capsule SCDF · 618512
  • Ursodiol Oral Capsule SCDFP · 2645659
  • Ursodeoxycholate Oral Product SCDG · 1159985
  • Ursodeoxycholate Pill SCDG · 1159986
  • Ursodiol Oral Product SCDGP · 2662119
  • Ursodiol Pill SCDGP · 2660380

Brand-Name Concepts

  • Ursodiol 200 MG Oral Capsule [Reltone] SBD · 2477896
  • Ursodiol 200 MG [Reltone] SBDC · 2477892
  • Ursodeoxycholate Oral Capsule [Reltone] SBDF · 2477893
  • Ursodiol Oral Capsule [Reltone] SBDFP · 2656234
  • Reltone Oral Product SBDG · 2477894
  • Reltone Pill SBDG · 2477895
  • Reltone BN · 2477891

📦 FDA Products & Package NDCs

6 products · 6 package NDCs
6 package NDCs map to RxCUI 412174 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
72887-0143-06 60 CAPSULE in 1 BOTTLE (72887-143-06) Ursodiol 200 mg FH2 Pharma LLC 2021-11-18
72887-0144-06 60 CAPSULE in 1 BOTTLE (72887-144-06) Ursodiol 400 mg FH2 Pharma LLC 2021-11-18
79739-7143-01 100 CAPSULE in 1 BOTTLE (79739-7143-1) Ursodiol 200 mg LGM PHARMA SOLUTIONS, LLC 2020-07-01
79739-7144-01 100 CAPSULE in 1 BOTTLE (79739-7144-1) Ursodiol 400 mg LGM PHARMA SOLUTIONS, LLC 2020-07-01
80056-0143-01 100 CAPSULE in 1 BOTTLE (80056-143-01) Reltone 200 mg Intra-Sana Laboratories 2021-02-15
80056-0144-01 100 CAPSULE in 1 BOTTLE (80056-144-01) Reltone 400 mg Intra-Sana Laboratories 2021-02-15
Observed labelers: FH2 Pharma LLC (2) · Intra-Sana Laboratories (2) · LGM PHARMA SOLUTIONS, LLC (2) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.